Net Income
Net Income
Revolution Medicines, Inc. Net Income decreased by 24.4% to -$453.82M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 112.6%, from -$213.42M to -$453.82M. Over 4 years (FY 2021 to FY 2025), Net Income shows a downward trend with a 56.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionNet Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026
How to read this metric
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
Detailed definition
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
Peer comparison
The most common metric for evaluating company performance against industry competitors.
Metric ID:
net_incomeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$44.30M | -$52.94M | -$52.68M | -$57.65M | -$61.22M | -$73.33M | -$56.51M | -$68.10M | -$98.30M | -$108.43M | -$161.54M | -$116.00M | -$133.23M | -$156.29M | -$194.57M | -$213.42M | -$247.79M | -$305.21M | -$364.89M | -$453.82M |
| QoQ Change | — | -19.5% | +0.5% | -9.4% | -6.2% | -19.8% | +22.9% | -20.5% | -44.3% | -10.3% | -49.0% | +28.2% | -14.9% | -17.3% | -24.5% | -9.7% | -16.1% | -23.2% | -19.6% | -24.4% |
| YoY Change | — | — | — | — | -38.2% | -38.5% | -7.3% | -18.1% | -60.6% | -47.9% | -185.9% | -70.3% | -35.5% | -44.1% | -20.4% | -84.0% | -86.0% | -95.3% | -87.5% | -112.6% |
Range-$453.82M – -$44.30M
CAGR+63.2%
Avg YoY Growth-64.5%
Median YoY Growth-54.2%
Current Streak8 quarters decline
Net Income at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s net income?
- Revolution Medicines, Inc. (RVMD) reported net income of -$453.82M in Q1 2026.
- How has Revolution Medicines, Inc.'s net income changed year-over-year?
- Revolution Medicines, Inc.'s net income decreased by 112.6% year-over-year, from -$213.42M to -$453.82M.
- What is the long-term trend for Revolution Medicines, Inc.'s net income?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s net income has grown at a 56.8% compound annual growth rate (CAGR), from -$187.09M to -$1.13B.
- What does net income mean?
- The total profit remaining after all costs, expenses, and taxes have been paid.